APA (7th ed.) Citation

Afferi, L., Spahn, M., Hayoz, S., Strebel, R. T., Rothschild, S. I., Seifert, H., . . . Petrausch, U. (2024). Safety and quality of cystectomy and pelvic lymph node dissection after neoadjuvant durvalumab and cisplatin/gemcitabine. BJU International, 134(3), 388. https://doi.org/10.1111/bju.16318

Chicago Style (17th ed.) Citation

Afferi, Luca, et al. "Safety and Quality of Cystectomy and Pelvic Lymph Node Dissection After Neoadjuvant Durvalumab and Cisplatin/gemcitabine." BJU International 134, no. 3 (2024): 388. https://doi.org/10.1111/bju.16318.

MLA (9th ed.) Citation

Afferi, Luca, et al. "Safety and Quality of Cystectomy and Pelvic Lymph Node Dissection After Neoadjuvant Durvalumab and Cisplatin/gemcitabine." BJU International, vol. 134, no. 3, 2024, p. 388, https://doi.org/10.1111/bju.16318.